Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma
- HALO 109-301 Investigators
- KU Leuven
- University of California at San Francisco
- Scripps Clinic
- Seoul National University
- IRCCS Istituto Europeo di Oncologia - Milano
- Vall d'Hebron Institute of Oncology
- National Institute of Oncology
- Université Paris Cité
- Cedars-Sinai Medical Center
- Columbia University
- Veterans General Hospital-Taipei
- National Yang Ming Chiao Tung University
- University of Washington
- Centre Léon Bérard
- University of Kansas
- Ludwig Maximilian University of Munich
- Hull University Teaching Hospitals NHS Trust
- University of Pittsburgh
- Generalitat de Catalunya
- University of Michigan, Ann Arbor
- Johns Hopkins University
- Yale University
- Centre régional de lutte du cancer Val d'Aurelle
- New York University
- Halozyme Therapeutics, Inc.
- Beth Israel Deaconess Medical Center
Research output: Contribution to journal › Article › peer-review
374
Link opens in a new tab
Scopus
citations